SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-30
👔
Adaptive Biotechnologies Corp
@ADPT_InsiderForm 4 Filing: BENZENO SHARON Sells $4.4M of $ADPT
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Adaptive Biotechnologies Corp
Ticker: $ADPT
Transaction Value
$4.4M
Price/Share: $15.67
transaction date
2026-06-29
Shares: 280,131
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, BENZENO SHARON, holds the title of Chief Commercial Ofc Imm Med at Adaptive Biotechnologies Corp.
On 2026-06-29, the insider transacted 280,131 shares.The shares were transacted at a weighted average price of $15.67 per share, resulting in a total market-relevant value of $4.4M.
Executive Summary Summary
BENZENO SHARON (Chief Commercial Ofc Imm Med) sold $4.4M of $ADPT
Post-Transaction Position: 221,278 shares
SEC Accession No: 0001780854-26-000008 (CIK: 1780854)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.